Login / Signup

Endothelial Dysfunction, a Marker of Atherosclerosis, Is Independent of Metabolic Syndrome in NAFLD Patients.

Jimmy NarayanHaribhakti Seba DasPreetam NathAyaskanta SinghDebakanta MishraPradeep Kumar PadhiShivaram Prasad Singh
Published in: International journal of hepatology (2020)
The markers of endothelial dysfunction are significantly higher in patients with NAFLD than controls.
Keyphrases
  • metabolic syndrome
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • insulin resistance
  • adipose tissue
  • patient reported outcomes
  • cardiovascular risk factors